Zentalis Pharmaceuticals, Inc. ZNTL
Set alert
1.96 USD -0.03 -1.51%
At close · Oct 30
1.96 0.00 -0.02%
After hours · Oct 30, 5:32 PM ET
1.86 Day range 1.99
1.28 52-week range 6.61
- YTD
- +45.19%
- 1 year
- +31.54%
- Open
- 1.99
- Prev close
- 1.99
- Mkt cap
- 192.32M
- Vol
- 1.33M
- Avg vol
- 1.21M
- EPS
- -1.96
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.86
- High
- 1.99
- Forward P/E
- -0.89
- Beta
- 1.74
- Short ratio
- 3.17
- Inst. own
- 98.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2024
- 50-d avg
- 3.31
- 200-d avg
- 6.71
- 1y target
- 9.50
1Y chart
Signals (40)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 27, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 19, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 1, 2026 | 1 month ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| RSI: Oversold | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 3, 2026 | 1 month ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| RSI: Overbought | Jun 30, 2026 | 4 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 19, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 22, 2026 | 6 months ago |
| RSI: Overbought | Apr 9, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| SMA: Bullish | Mar 26, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 20, 2026 | 7 months ago |
| SMA: Bearish | Mar 18, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 10, 2026 | 7 months ago |
| SMA: Bullish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 6, 2026 | 9 months ago |
| RSI: Overbought | Jan 6, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 26, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 21, 2025 | 11 months ago |
Compare ZNTL
Chart and line up ZNTL against other symbols or a saved comparison set.
- ZNTL Zentalis Pharmaceuticals, Inc.
1.96
-0.03 -1.51%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | ZNTL | SPY | QQQ |
|---|---|---|---|
| Last price | 1.96 | 755.72 | 690.49 |
| Change | -0.03 | -13.64 | -24.85 |
| Change % | -1.51% | -1.77% | -3.47% |
| Open | 1.99 | 761.38 | 697.13 |
| Day high | 1.99 | 761.46 | 698.63 |
| Day low | 1.86 | 750.36 | 683.45 |
| Previous close | 1.99 | 769.36 | 715.34 |
| Volume | 1.33M | 77.70M | 85.24M |
| Average volume | 1.21M | 41.22M | 34.57M |
| Market cap | 192.32M | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -1.96 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 6.61 | 779.09 | 759.66 |
| 52-week low | 1.28 | 631.97 | 558.28 |
| 1-week return | -11.31% | -0.559233% | -1.97% |
| 1-month return | -29.24% | -0.906075% | -6.66% |
| 3-month return | -60.16% | +1.89% | +1.02% |
| 6-month return | -51.12% | +5.16% | +3.41% |
| Year-to-date return | +45.19% | +10.82% | +12.40% |
| 1-year return | +31.54% | +11.16% | +10.29% |
| 2-year return | -28.21% | +32.90% | +42.71% |
| 50-day moving average | 2.98 | 767.63 | 725.41 |
| 200-day moving average | 3.46 | 728.53 | 679.17 |
| Target price | 9.50 | — | — |
| Beta | 1.74 | 0.00 | 0.00 |
| Short ratio | 3.17 | — | — |
| Institutional ownership | 98.01% | — | — |